The pursuit of UHC and resilient health systems is increasingly shaped by the role of commercial actors across health and non-health sectors. Private sector entities—including healthcare providers, pharmaceutical and medical technology companies, insurers, digital health firms, and supply chain actors—are central to financing, service delivery, innovation, and emergency response. Their contributions have been critical in expanding access to care, accelerating technological advancement, and supporting health system responses during crises such as the COVID-19 pandemic.

At the same time, the commercial determinants of health—defined as the systems, practices, and pathways through which commercial actors influence health outcomes—pose significant challenges. These include inequities in access driven by pricing and market concentration, regulatory capture, fragmented service delivery, and misaligned incentives that may prioritize profit over public health goals.

These dynamics are particularly important in the context of the growing burden of noncommunicable diseases (NCDs) and rapidly ageing populations, which require continuous, integrated, and often costly care. Commercial actors shape not only service delivery but also health risks, through the production and marketing of health-related products, as well as the organization of care systems for chronic disease and long-term care.

The influence of commercial sectors cuts across all three dimensions of UHC:

1. Service Coverage and Access

Commercial actors significantly shape the availability of health services, medicines, and technologies. They expand access through private provision, innovation, and digital health solutions. This is particularly relevant for NCD management and ageing-related care needs, which require sustained and accessible services. However, access remains uneven, with market-driven provision often concentrated in urban or higher-income settings, leaving gaps in underserved populations and contributing to fragmented care pathways.

2. Population Coverage

Achieving inclusive population coverage requires integrating diverse population groups into UHC systems. While private insurance and service provision can complement public coverage, they may also contribute to segmentation, where access and quality differ across socioeconomic groups. Ensuring equitable population coverage requires effective stewardship, including contracting, accreditation, and integration of private providers within national health systems.

3. Financial Protection

Commercial dynamics strongly influence affordability. Pricing strategies, provider payment systems, and market structures can drive high out-of-pocket spending, especially for chronic disease management and long-term care in ageing societies. At the same time, strategic purchasing and well-designed public–private arrangements can enhance efficiency and reduce financial hardship if aligned with UHC objectives.

Global momentum toward Universal Health Coverage (UHC) has been reinforced by the joint ambition of the World Bank and WHO to ensure that 1.5 billion more people are better protected from health emergencies and have access to essential health services without financial hardship. Achieving this target requires not only strengthening public systems but also strategically engaging commercial sectors that increasingly shape both health systems and population health outcomes.

Key dynamics shaping this landscape include:

• Market-driven inequities in access to essential health services, medicines, and technologies, particularly in low- and middle-income countries
• Fragmentation of service delivery, where unregulated or poorly integrated private providers undermine continuity and quality of care
• Pricing and procurement challenges, including high out-of-pocket expenditures and inefficiencies in purchasing arrangements
• Commercial drivers of NCD risk, including marketing and availability of unhealthy products
• Rising demand for long-term care in ageing societies, increasingly mediated through private markets
• Digital transformation, where private sector innovation in telemedicine, AI, and health data systems creates both opportunities and risks related to access, governance, and data privacy
• Supply chain vulnerabilities, exposed during global crises, where reliance on commercial networks can both enable rapid response and exacerbate inequities
• Governance and regulatory gaps, particularly in managing conflicts of interest and ensuring accountability of private actors
• Opportunities for strategic purchasing and public–private partnerships (PPPs) to align incentives and improve efficiency and outcomes

Effectively leveraging commercial sectors while safeguarding public health objectives is therefore central to advancing UHC—across service coverage, population coverage, and financial protection—and strengthening resilience against future shocks.